Insider Transactions Reported by 16 Insiders of Relay Therapeutics, Inc.

Symbol
RLAY on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Relay Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanjiv Patel President and CEO, Director $12,672,981 -$1,173,631 -8.5% 13 Jan 2026
Donald A. Bergstrom President, R&D $3,549,397 -$603,575 -15% 27 Jan 2026
Peter Rahmer Chief Corporate Development Officer $2,337,354 -$500,612 -18% 27 Jan 2026
Thomas Catinazzo Chief Financial Officer $2,329,735 -$602,457 -21% 09 Mar 2026
Brian Adams Chief Legal Officer $1,367,016 -$118,265 -8% 28 Jul 2025
Jami Rubin Director $338,900 06 Jun 2025
Andy Porter Chief Administrative Officer $272,339 28 Oct 2022
Laura Shawver Director 03 Jun 2024
Sekar Kathiresan Director 06 Jun 2025
LINDA A. HILL Director 06 Jun 2025
Claire Mazumdar Director 09 Jun 2025
LONNEL COATS Director 04 Nov 2025
Habib J. Dable Director 04 Nov 2025
Mark Murcko Director 06 Jun 2025
Alexis Borisy Director 06 Jun 2025
DOUGLAS S. INGRAM Director 06 Jun 2025

Recent Insider Transactions by Companies or Individuals for Relay Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.